Pathophysiology and Management of Acute Coronary Syndromes

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this podcast from the BMJ Group, Mark de Belder, MD, a consultant cardiologist, speaks to James McLenachan, MRCP, a fellow consultant cardiologist, and Keith Channon, MD, professor of cardiovascular medicine at the University of Oxford, about the pathophysiology and management of acute coronary syndromes. To listen to the podcast online, click here. To download it, click here.
Related Articles
The FDA has granted priority review to expand the use of AstraZeneca’s ticagrelor (Brilinta).
Here are the key points and rationale behind the lower blood pressure target.
While the FDA only recommends daily aspirin for patients who have experienced major cardiovascular events, about half of older adults in the United States take aspirin regularly.
Energy drink overconsumption has dangerous cardiac and neurologic consequences in adolescents.
Latest Issues
  • photo
    Pharmacy Times
    photo
    Health-System Edition
    photo
    Directions in Pharmacy
    photo
    OTC Guide
    photo
    Generic Supplements
  • photo
    Pharmacy Careers
    photo
    Specialty Pharmacy Times
    photo
    Generic
$auto_registration$